Ed Cahill

Ed Cahill is currently serving as the Chief Scientific Officer at Rosemont Pharmaceuticals since July 2022. Prior to this, they were the Head of Early MSAT - Global Technical Operations at Amicus Therapeutics from October 2019 to July 2022. Ed also held various roles at Teva Pharmaceuticals from October 2006 to October 2019, including Senior Director of Manufacturing, Science and Technology, Head of New Sterile Technology, and Global Sterile Technology Manager. They previously worked at AstraZeneca as a Product Development Manager from 2000 to 2006 and at Medeva as a Team Leader from 1994 to 2000.